---  
layout: startup_page  
title: "Antiverse"  
id: "antiverse.io"  
permalink: "/antiverseantiverse.io10152024/"  
website: "https://www.antiverse.io/"  
funding_round: "Seed"  
funding_amount: "$4.6M"  
investors: "i&i Biotech Fund I (i&i Bio), Kadmos Capital, InnoSpark Ventures, UKI2S (managed by Future Planet Capital), Tensor Ventures, AngelHub"  
about: "Antiverse is a techbio company employing a machine-learning-centered approach to design antibodies for challenging targets like GPCRs and ion channels. Its platform uses target-specific libraries to enhance predictive accuracy, accelerating the antibody discovery process to six months and bringing needed therapies to patients faster. This approach addresses the limited number of existing GPCR-targeting antibodies despite their importance in drug development."  
markets: "Biotechnology, Pharmaceuticals, AI, Machine Learning, Drug Discovery, Other Healthcare Technology Systems, Big Data, LOHAS & Wellness, HealthTech, Life Sciences"  
hq: "Cardiff, Wales, United Kingdom"  
founded_year: "2017"  
linkedin: "https://www.linkedin.com/company/antiverse"  
twitter: "https://twitter.com/AntiverseHQ"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/antiverse"  
pitchbook: "https://pitchbook.com/profiles/company/224267-86"  

date_display: "15-Oct-2024"  
date: "2024-10-15"

# SEO Optimization  
meta_title: "Antiverse - Seed Funding ($4.6M)"  
meta_description: "Antiverse, Antiverse is a techbio company employing a machine-learning-centered approach to design antibodies for challenging targets like GPCRs and ion channels..."  
meta_keywords: "Antiverse, Biotechnology, Pharmaceuticals, AI, Machine Learning, Drug Discovery, Other Healthcare Technology Systems, Big Data, LOHAS & Wellness, HealthTech, Life Sciences, Seed funding"  
canonical_url: "https://startup.projectstartups.com/antiverseantiverse.io10152024/"  
---